Dishman Pharmaceuticals and Chemicals has reported 37.35% rise in consolidated net profit at Rs 31.29 crore for the quarter ended March 31. The company had posted net profit of Rs 22.78 crore for the quarter ended March 31, 2011.

The company’s net sales stood at Rs 350.18 crore for the quarter ended March 31, 2012, as against Rs 344.40 crore for the corresponding quarter in the previous fiscal.

Consolidated net profit of the company for the year ended March 31, 2012 however declined to Rs 56.76 crore, as against Rs 79.97 crore for the year ago period.

Dishman Pharmaceuticals and Chemicals is engaged in manufacturing of Bulk API, Intermediates, Specialties and Quats. The company has started production of a range of phase transfer catalysts and quaternary ammonium and phosphonium compounds in 1989.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×